Literature DB >> 24894814

Exogenous expression of WT1 gene influences U937 cell biological behaviors and activates MAPK and JAK-STAT signaling pathways.

Xiaoyan Li1, Yan Li2, Tian Yuan2, Qing Zhang2, Yujiao Jia2, Qihui Li2, Lei Huai2, Pei Yu2, Zheng Tian2, Kejing Tang2, Min Wang2, Haiyan Xing2, Qing Rao2, Yingchang Mi3.   

Abstract

Wilms' tumor 1 (WT1) gene plays important roles in leukemogenesis. To further explore its underlying mechanisms, we transfected two WT1 isoforms, WT1(+17AA/-KTS) and WT1(+17AA/+KTS) into U937, a WT1-null monoblastic cell line, studied their effects on migration, colony formation, apoptosis, gene expression and pertinent signaling pathways of U937 cells. The results showed that WT1(+17AA/-KTS), but not WT1(+17AA/+KTS), enhanced migration and colony forming abilities of U937 cells, and suppressed etoposide-induced U937 cell apoptosis. Transfection of WT1 isoforms activated gene expressions of chemokine, and induced up-regulation of signaling molecules involved in JAK-STAT and MAPK signaling pathways. This study showed that exogenous expression of WT1 gene remarkably affected biological behaviors of U937 cells, and these effects are possibly mediated by up-regulation of genes related to chemokine, JAK-STAT and MAPK signaling pathways.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Leukemia; Microarray; Signaling pathway; Target gene; Wilms’ tumor 1 (WT1) gene

Mesh:

Substances:

Year:  2014        PMID: 24894814     DOI: 10.1016/j.leukres.2014.05.006

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  4 in total

1.  Regulation of HtrA2 on WT1 gene expression under imatinib stimulation and its effects on the cell biology of K562 cells.

Authors:  Lixia Zhang; Yan Li; Xiaoyan Li; Qing Zhang; Shaowei Qiu; Qi Zhang; Min Wang; Haiyan Xing; Qing Rao; Zheng Tian; Kejing Tang; Jianxiang Wang; Yingchang Mi
Journal:  Oncol Lett       Date:  2017-07-20       Impact factor: 2.967

2.  WT1-AS promotes cell apoptosis in hepatocellular carcinoma through down-regulating of WT1.

Authors:  Long Lv; Gong Chen; Jianping Zhou; Jun Li; Jianping Gong
Journal:  J Exp Clin Cancer Res       Date:  2015-10-13

3.  WT1 facilitates the self-renewal of leukemia-initiating cells through the upregulation of BCL2L2: WT1-BCL2L2 axis as a new acute myeloid leukemia therapy target.

Authors:  Bin Zhou; Xianghong Jin; Weiwei Jin; Xingzhou Huang; Yanfei Wu; Haiying Li; Weijian Zhu; Xiaoyi Qin; Haige Ye; Shenmeng Gao
Journal:  J Transl Med       Date:  2020-06-24       Impact factor: 5.531

4.  A novel variant translocation (1;9)(p22;q34) resulting in a DEK/NUP214 fusion gene in a patient with acute myeloid leukemia: A case report.

Authors:  Qishan Hao; Qi Zhang; Chengwen Li; Shuning Wei; Qinghua Li; Yang Song; Yingchang Mi
Journal:  Oncol Lett       Date:  2017-10-03       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.